From the Journals

CVD risk high in individuals who once had metabolically healthy obesity

View on the News

Metabolically healthy obesity not so healthy after all

While obesity has inherent adverse effects on cardiometabolic parameters and cardiovascular disease (CVD) risk factors, metabolically healthy obesity (MHO) has emerged as a categorization of obese individuals who may not be at increased CVD risk because of relatively normal levels of lipids, blood pressure, and glucose.

An increasing body of research, however, including the present study by Dr. Mongraw-Chaffin and colleagues, highlights “dangers and long-term outcomes” of the MHO phenotype, Dr. Prakash Deedwania and Dr. Carl J. Lavie wrote in an editorial.

The analysis of 6,809 individuals in the Multi-Ethic Study of Atherosclerosis found that MHO is not a stable condition, as almost one-half of individuals developed metabolic syndrome over 12.2 years of follow-up, they noted.

Moreover, CVD risk was indeed elevated in these individuals with “unstable” MHO.

“Clearly, therefore, prevention of obesity in the first place is most prudent,” Dr. Deedwania and Dr. Lavie said in their editorial. “Prevention of progressive weight gain over time among the overweight and mildly obese is also of high importance to prevent development of metabolic syndrome and subsequent risk of CVD.”

If individuals with MHO can be identified early, the authors said, there is an excellent opportunity for primary prevention through lifestyle changes, including weight loss and regular physical exercise that might prevent MHO from converting to metabolically unhealthy obesity.

“Such population-wide healthy interventions are the only hope of preventing the oncoming tsunami of metabolic syndrome, diabetes, and CVD,” the editorial authors concluded.

Prakash Deedwania, MD, is with the University of California at San Francisco School of Medicine Program at Fresno. Carl J. Lavie, MD, is with the John Ochsner Heart and Vascular Institute, New Orleans, and the University of Queensland in Brisbane, Australia. These comments are derived from their editorial in the Journal of the American College of Cardiology ( 2018 May 1;71[17]:1866-8) . Both authors reported they had no relevant relationships to disclose.


 

FROM THE JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The results mean that MHO represents an opportunity for primary prevention of CVD, they added.

“Prevention of incident metabolic syndrome and resulting CVD at the population level will necessitate the prevention of obesity,” they explained in a discussion of the results.

Dr. Mongraw-Chaffin and her associates reported that they had no relevant relationships to disclose.

SOURCE: Mongraw-Chaffin M et al. J Am Coll Cardiol 2018 May 1;71(17):1857-65.

Pages

Recommended Reading

Type 2 diabetes remitted with low-calorie diet
MDedge Cardiology
Metabolic and bariatric surgery reduces CVD risk in severely obese adolescents
MDedge Cardiology
VIDEO: Lean body mass linked to atrial fib etiology
MDedge Cardiology
Bariatric surgery comes with some risk of complications
MDedge Cardiology
Pre–bariatric surgery weight loss improves outcomes
MDedge Cardiology
Overweight and obese individuals face greater cardiovascular morbidity
MDedge Cardiology
Interleukin-1 antagonist boosts testosterone in obese men
MDedge Cardiology
MDedge Daily News: Why low-calorie sucralose may fuel weight gain
MDedge Cardiology
Being overweight as a child increases the risk of developing diabetes
MDedge Cardiology
Life and health are not even across the U.S.
MDedge Cardiology